Abstract

Vitamin D insufficiency or deficiency during pregnancy has been associated with an increased risk of preeclampsia. Increased placental cyclooxygenase-2 (COX-2) activity was proposed to contribute to the inflammatory response in preeclampsia. This study was to investigate if vitamin D can benefit preeclampsia by inhibiting placental COX-2 expression. Placenta tissues were obtained from 40 pregnant women (23 normotensive and 17 preeclampsia). miR-26b-5p expression was assessed by quantitative PCR. Vitamin D receptor (VDR) expression and COX-2 expression were determined by immunostaining and Western blot. HTR-8/SVneo trophoblastic cells were cultured in vitro to test anti-inflammatory effects of vitamin D in placental trophoblasts treated with oxidative stress inducer CoCl2. 1,25(OH)2D3 was used as bioactive vitamin D. Our results showed that reduced VDR and miR-26b-5p expression, but increased COX-2 expression, was observed in the placentas from women with preeclampsia compared to those from normotensive pregnant women. Transient overexpression of miR-26b-5p attenuated the upregulation of COX-2 expression and prostaglandin E2 (PGE2) production induced by CoCl2 in placental trophoblasts. 1,25(OH)2D3 treatment inhibited CoCl2-induced upregulation of COX-2 in placental trophoblasts. Moreover, miR-26b-5p expression were significantly upregulated in cells treated with 1,25(OH)2D3, but not in cells transfected with VDR siRNA. Conclusively, downregulation of VDR and miR-26b-5p expression was associated with upregulation of COX-2 expression in the placentas from women with preeclampsia. 1,25(OH)2D3 could promote miR-26b-5p expression which in turn inhibited COX-2 expression and PGE2 formation in placental trophoblasts. The finding of anti-inflammatory property by vitamin D through promotion of VDR/miR-26b-5p expression provides significant evidence that downregulation of vitamin D/VDR signaling could contribute to increased inflammatory response in preeclampsia.

Highlights

  • Vitamin D insufficiency or deficiency during pregnancy has been associated with an increased risk of preeclampsia

  • The exaggerated maternal inflammatory response in preeclampsia is attributed to the hypoxic placenta which is associated with abnormal production of c­ ytokines7, ­debris[8], and p­ rostaglandins[9], such as thromboxane (­ TXA2) and prostacyclin ­(PGI2), by placental trophoblast cells. ­TXA2 is a potent vasoconstrictor, while ­PGI2 is a vasodilator

  • To determine if reduced miR-26b-5p expression contributes to the activated COX-2/prostaglandins system that are relevant to preeclampsia, we examined the role of miR-26b-5p in the oxidative stress-induced inflammatory response

Read more

Summary

Introduction

Vitamin D insufficiency or deficiency during pregnancy has been associated with an increased risk of preeclampsia. Increased placental cyclooxygenase-2 (COX-2) activity was proposed to contribute to the inflammatory response in preeclampsia. Our results showed that reduced VDR and miR-26b-5p expression, but increased COX-2 expression, was observed in the placentas from women with preeclampsia compared to those from normotensive pregnant women. Transient overexpression of miR-26b-5p attenuated the upregulation of COX-2 expression and prostaglandin ­E2 ­(PGE2) production induced by ­CoCl2 in placental trophoblasts. Downregulation of VDR and miR-26b-5p expression was associated with upregulation of COX-2 expression in the placentas from women with preeclampsia. Preeclampsia is a placentally induced disorder of p­ regnancy[6] According to this theory, the exaggerated maternal inflammatory response in preeclampsia is attributed to the hypoxic placenta which is associated with abnormal production of c­ ytokines7, ­debris[8], and p­ rostaglandins[9], such as thromboxane (­ TXA2) and prostacyclin ­(PGI2), by placental trophoblast cells. Inhibition of COX-2/ PGE2 signaling might be beneficial in this disease

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call